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INTRODUCTION {#s1}
============

Globally speaking, Hepatitis A is a great concern for health care systems. The reported incidence of Hepatitis A is approximately 1.4 million cases worldwide, but the true incidence is believed to be much higher.^[@R01]^ While hepatitis A is often asymptomatic in children, it can become a serious, even deadly disease in adolescents and adults.^[@R02]-\ [@R04]^

Improvements in hygiene and socioeconomic conditions worldwide have resulted in lower disease incidence.^[@R05]^ A decrease in incidence during childhood leads to more susceptible adolescents and adults. In countries with lower incidence rates, the chance of an outbreak is minimal, hence universal vaccination is not cost effective. Thus universal vaccination is recommended only in countries that experience an epidemic shift from high to low incidence; vaccination in other countries is recommended only for targeted high risk groups.^[@R06]^

HAV is primarily transmitted through water, food and direct contact with an infected person. Health workers have a higher chance of direct contact with patients infected with hepatitis A and are at a higher risk compared to the general population.^[@R07]-\ [@R10]^ Although some studies imply that using personal protective measures would lower the chance of infection to the level of the general population,^[@R11]^ ideal protective measures are not practical in many situations. Several outbreaks among hospital health care workers have been reported.^[@R09],[@R10]^

Hepatitis A has an intermediate endemicity in the Middle East.^[@R12],[@R13]^ One of the largest recent studies of HAV seroprevalence in Iran gathered samples from three provinces including the capital. This study has reported an HAV prevalence of 86% among the general population.^[@R14]^ Universal vaccination against HAV is not currently a part of the Iranian vaccination program. A prevalence rate this high is indicative of a high risk of infection for people who are not immune to the disease.^[@R15]^

Our study aims to investigate the HAV seroprevalence of students enrolled in health sciences programs who intend to become health workers.

MATERIALS AND METHODS {#s2}
=====================

Study population {#s2-1}
----------------

During the year 2011, 1864 students enrolled in Tehran University of Medical Sciences. These students were from various parts of Iran enrolled in health science fields such as medicine, nursing, midwifery, and dentistry. Blood samples are regularly collected from all new students for screening and health insurance purposes. We used the serums of the previously collected samples from all students who consented to the test. A total of 1864 serum samples were collected and transferred to laboratories for analysis.

Assays {#s2-2}
------

For analysis, one ml of serum was used. Each sample was kept in a dry tube and maintained at -20°C until analysis. Anti-HAV IgG status was determined by ELISA. The cutoffs were established according to the manufacturer.

Statistical analysis {#s2-3}
--------------------

For data analysis, we used SPSS Statistics version 21 (IBM Corporation, NY, US) The HAV antibody prevalence was calculated for the entire population and separately for each gender. We calculated the strength of the association between gender, measured seroprevalence and calculated its relative risk.

RESULTS {#s3}
=======

During the year 2011, 1864 students enrolled in Tehran University of Medical Sciences. From the 1864 samples that were collected, 51 were unsuitable for analysis. The characteristics of the study population are detailed in [Table 1](#T1){ref-type="table"} .

###### Characteristics of the study population.

  -------- ------------------------ ---------------------- ------------------------
           **Number of subjects**   **Mean age (years)**   **Standard deviation**
  Female   1262                     20.8                   3.91
  Male     602                      20.56                  3.58
  Total    1864                     20.73                  3.8
  -------- ------------------------ ---------------------- ------------------------

From the 1813 samples analyzed, a total of 970 (53.5%) were negative for anti-HAV antibodies, 722 (39.8%) were positive and 121 (6.7%) were equivocal. We observed significantly higher seropositive results in males (54%) compared to females (37%; RR = 1.46; 95% CI: 1.31-1.62).

DISCUSSION {#s4}
==========

Numerous studies have been carried out on the seroprevalence of HAV in different regions of Iran ([Table 2](#T2){ref-type="table"} ).^[@R14],[@R16]-[@R20]^ Our results compared with those studies showed a considerably lower prevalence of HAV-antibody in our subjects. To decrease the possibility of age bias, we compared our results with the reported seroprevalence in young adult subgroups of those studies. Our results were still considerably lower.

###### Recent studies on hepatitis A virus (HAV) seroprevalence in Iran.

  --------------------------------- ---------------- ---------------- ----------------------------------------------------- ----------------- -------------------------------------------------------
  **Region(s)**                     **Citation**     **Study year**   **Seroprevalence data**                               **Sample size**   **Population/comments**

  **Tehran, Hormozgan, Golestan**   Merat, 2010      2006             73% (age 18-29),\                                     1869              Rural and urban populations
                                                                      94% (age 30-45),\                                                       
                                                                      98% (age 46-65)                                                         

  **Sari**                          Alian, 2011      2007             8.9% (age 1-5),\                                      1034              Rural and urban populations
                                                                      15.8% (age 5-15), 64.3% (age 15-25)                                     

  **Tehran**                        Elikaei, 2008    2005-2006        86%                                                   407               Healthy blood donors

  **Fars**                          Taghavi, 2011    2008-2009        79.3% (age \<20), 91.3% (age 20-30), 99% (age \>30)   1050              Healthy individuals referred for premarital screening

  **Tehran**                        Mohebbi, 2012    2006-2007        90%                                                   551               General population

  **Qazvin**                        Ramezani, 2011   2008             94.9%                                                 351               Healthy blood donors
  --------------------------------- ---------------- ---------------- ----------------------------------------------------- ----------------- -------------------------------------------------------

The reason for this difference could be due to an epidemiologic shift. As general health improves, the prevalence of HAV decreases. Similar shifts have been reported from neighboring countries in recent years.^[@R21]-\ [@R24]^ It also could be due to a socioeconomic difference between our participants and the general population, as our participants had at least 12 years of education prior to university enrollment. However, further studies are required to prove the causality of either of these factors.

We also observed a significantly higher seropositivity among male students. We have no explanation for this finding but it might be related to the traditional Iranian culture in which boys are exposed to the community and social life earlier than girls, thus there might be more exposure to HAV.

Regardless of the cause, these results show that our study population is a group with a low prevalence of HAV-antibody and therefore prone to HAV infection and its complications. The complications and mortality of hepatitis A in adults and the older population are much more frequent which makes vaccination attractive.^[@R25]^ The seroprevalence of HAV may still be too high in the Iranian general population for recommending routine vaccination.^[@R14]^ However, the trend towards lower prevalence in younger age groups and people from urban areas points towards the possible benefit of vaccination in these subgroups.^[@R26]^ In particular, medical professions with higher exposure to HAV may require vaccination before entering clinical employment. A targeted vaccination for health science students at entrance to the university may be of benefit.
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